Insider Shareholders with Direct Ownership of Surface Oncology, Inc. (SURF)
This section provides a comprehensive overview of the insiders with direct ownership of Surface Oncology, Inc. (SURF). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Surface Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novartis Institutes For Bio Medical Research, Inc.
> 10% Shareholder |
3,948,482 | 0 | 3,948,482 $0 | 1 |
Apr 23, 2018
Added 16.26%
|
|
Atlas Venture Fund Ix, L.P.
> 10% Shareholder |
3,281,817 | 1,700,000 | 2,945,453 $0 | 2 |
Dec 17, 2020
Reduced 36.59%
|
| 886,716 | 0 | 886,716 $0 | 1 |
Apr 23, 2018
Added 50.0%
|
|
|
Liisa I Nogelo
Chief Legal Officer |
0 | 26,325 | 53,675 $0 | 1 |
Jul 21, 2021
Reduced 32.91%
|
|
Henry C. Rath
Chief Business Officer |
38,000 | 50,647 | 0 $0 | 3 |
Sep 08, 2023
Reduced 100.0%
|
|
Alison Oneill
Chief Medical Officer |
83,000 | 83,000 | 0 $0 | 6 |
Sep 08, 2023
Reduced 100.0%
|
|
Robert W. Ross
Chief Executive Officer |
56,000 | 161,000 | 0 $0 | 12 |
Sep 08, 2023
Reduced 100.0%
|
|
Jessica Fees
Chief Financial Officer |
44,278 | 140,183 | 0 $0 | 9 |
Sep 08, 2023
Reduced 100.0%
|
|
Vito J. Palombella
Chief Scientific Officer |
38,000 | 118,000 | 0 $0 | 4 |
Sep 08, 2023
Reduced 100.0%
|
|
Jeff Goater
Director |
255,000 | 517,000 | 0 $0 | 12 |
Sep 08, 2023
Reduced 100.0%
|
|
Chandra Adams
Deputy GC |
0 | 27,785 | 0 $0 | 2 |
Sep 08, 2023
Reduced 100.0%
|